Three ways UNICEF provides oxygen

Oxygen is in the air we breathe, the water we drink, and a critical part of the development of life. However, medical oxygen (at least 82 per cent pure and free from contamination) is critical for treating patients with respiratory diseases. Unfortunately, it is often unavailable in many parts of the world.

UNICEF is urgently expanding access to oxygen and here are three ways how we do it.

Throughout 2020 and 2021 the need has been evident: countries across the world urgently require oxygen equipment. Since January 2020, UNICEF has delivered 20,629 oxygen concentrators to 94 countries. These machines take in air from the environment, remove nitrogen and produce a continuous source of oxygen. In addition, UNICEF has distributed 42,593 oxygen accessories (such as pulse oximeters, flow splitters, oxygen analyzers and humidifier bottles) and 1,074,754 consumables (such as nasal cannula, face masks and tubing) – essential equipment to ensure oxygen therapy can be safely administered to patients.*

To learn more, read our SPRINT in Senegal story that highlights the essential equipment required for delivering oxygen therapy.

The need for medical oxygen goes far beyond the COVID-19 emergency. It's a crucial commodity required for a range of health needs - like treating sick newborns and children with pneumonia, supporting mothers with birth complications, and keeping patients stable during surgeries. To ensure long-term solutions, UNICEF is working with governments to build oxygen systems. This can involve installing oxygen plants, developing cylinder delivery networks, and/or purchasing concentrators, in addition to training health staff on diagnosing respiratory illnesses and safely administering oxygen. The Oxygen System Planning Tool is helping countries map out their needs while technical support is provided by UNICEF staff and biomedical engineers.

To learn more, read our World Pneumonia Day story, that highlights system-building efforts in several countries.

Via our oxygen-focused innovations, the response can come at a low cost and high impact. The approach involves working with businesses, academia, manufactures, governments, and field partners to identify, develop and scale fit-for-purpose and value-for-money products that respond to the needs of children and families. Some current projects include:

To learn more about these projects and our approach to innovation, visit the product innovation webpage.

While there are enormous global efforts underway, the need for oxygen continues to grow. By addressing the current gap, we not only provide urgent treatment to COVID-19 patients but can save the lives of newborns and children who require oxygen to survive. UNICEF is part of the Access to COVID-19 Tools Accelerator (ACT-A) COVID-19 Oxygen Emergency Taskforce to respond to COVID-19 surges in oxygen demand. Increased support from governments and donors to fill the financing needs is crucial to ensure equitable access to COVID-19 treatment which includes oxygen therapy.

To learn more about ACT-A and how to support our work, visit our ACT-A Supplies Financing Facility webpage.

* Data as of 19 May 2021.